BE of Euthyrox® Tablets (Merck Nantong Versus Merck Darmstadt Sites)
Status:
Not yet recruiting
Trial end date:
2023-01-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to demonstrate bioequivalence (BE) between Euthyrox® tablets
manufactured at Merck Nantong (Test Euthyrox) versus the tablets manufactured at Merck
Darmstadt (Reference Euthyrox).
Phase:
Phase 1
Details
Lead Sponsor:
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany